Our data demonstrating the in vivo accumulation of CPs and CColl within tissues during chronic increase of urea, as seen in CKD, may be combined with previous in vitro studies to explain the involvement of CPs in the development of long-term complications of CKD, especially those linked to cardiovascular damage and the relentless progression of renal dysfunction. This evidence concerns the gene CAD and chronic kidney disease.